openPR Logo
Press release

Osseointegration Implants Market Set for Steady Expansion by 2032, Driven by Innovation and Growing Surgical Volumes | DelveInsight

04-28-2025 09:50 PM CET | Business, Economy, Finances, Banking & Insurance

Press release from: ABNewswire

Osseointegration Implants Market

Osseointegration Implants Market

The osseointegration implants market is projected to expand at a CAGR of 7.11% between 2024 and 2030. This growth is largely driven by the rising incidence of orthopedic conditions. Additionally, the increasing prevalence of dental disorders and the surge in product approvals highlight advancements in orthopedic and dental technologies, leading to better patient outcomes and fueling the expansion of the osseointegration implants market throughout the forecast period.
Osseointegration Implants Market Set for Steady Expansion by 2032, Driven by Innovation and Growing Surgical Volumes | DelveInsight

DelveInsight's Osseointegration Implants Market Insights report [https://www.delveinsight.com/report-store/osseointegration-implants-market?utm_source=abnewswire&utm_medium=market&utm_campaign=kpr] provides the current and forecast market analysis, individual leading Osseointegration Implants companies' market shares, challenges, Osseointegration Implants market drivers, barriers, and trends, and key Osseointegration Implants companies in the market.

Key Takeaways from the Osseointegration Implants Market Report

- The Osseointegration Implants market is projected to grow at a moderate CAGR from 2025 to 2032.

- As per DelveInsight estimates, North America is anticipated to dominate the global Osseointegration Implants market during the forecast period.

- Notable Osseointegration Implants companies such as Medtronic, Stryker, Neoss, Onkos Surgical, CartiHeal Ltd., RevBio, Inc., ZimVie Inc., Zimmer Biomet, OSSTEM IMPLANT CO., LTD., CONMED Corporation, Smith & Nephew, BioHorizons, Camlog, Straumann AG Group, Align Technology, Inc., BEGO GmbH and Co. KG, MEGA'GEN IMPLANT CO.,LTD., Henry Schein, Inc., MIS Implants Technologies, Nobel Biocare, and several others are currently operating in the Osseointegration Implants market.

- In April 2024, Onkos Surgical announced the first FDA De Novo approval for an antibacterial coating developed specifically for tumor and revision orthopedic implants.

*
In September 2023, Neoss Registered Group unveiled a new Multi-Unit Abutment as part of their Neoss4+ Trademark Treatment Solution for dental implants. This abutment offers a 10-degree option with a reduced vertical height and includes a clinical screw fixed within the abutment to prevent it from being lost during placement.

*
In December 2022, NYU Langone's Center for Amputation Reconstruction launched an osseointegration program featuring an FDA-approved implant system.

*
In March 2022, CartiHeal Ltd. received FDA approval for the Agili-C Trademark implant, designed for treating knee joint surface lesions, as well as chondral and osteochondral defects.

To read more about the latest highlights related to the Osseointegration Implants market, get a snapshot of the key highlights entailed in the Global Osseointegration Implants Market Report [https://www.delveinsight.com/sample-request/osseointegration-implants-market?utm_source=abnewswire&utm_medium=market&utm_campaign=kpr]

Osseointegration Implants Overview

Osseointegration implants are advanced orthopedic and dental devices designed to integrate directly with the bone, providing a stable foundation for prosthetic limbs, dental restorations, and other medical devices. This technology is most commonly used in patients requiring joint replacements, limb prosthetics, and dental implants, offering enhanced comfort and improved functionality.

Osseointegration Implants Market Insights

North America is anticipated to hold the largest share of the osseointegration implants market in 2023 compared to other regions. Several factors are driving this growth, including the high prevalence of orthopedic and dental conditions such as osteoarthritis, osteoporosis, and tooth loss. Moreover, ongoing technological advancements and a strong environment for product approvals and new product launches are expected to further propel the market for osseointegration implants.

According to the American College of Prosthodontists (2022), over 36 million Americans were edentulous, and around 120 million people had at least one missing tooth in 2020. These figures are projected to rise significantly over the next two decades.

To know more about why North America is leading the market growth in the Osseointegration Implants market, get a snapshot of the Osseointegration Implants Market Outlook [https://www.delveinsight.com/report-store/osseointegration-implants-market?utm_source=abnewswire&utm_medium=market&utm_campaign=kpr]

Osseointegration Implants Market Dynamics

According to the latest figures from the World Health Organization (WHO) (2023), around 528 million people worldwide are affected by osteoarthritis, while 18 million are living with rheumatoid arthritis. The knee is the most commonly impacted joint, accounting for 365 million cases, followed by the hip and hand joints. The rising prevalence of arthritis and rheumatoid arthritis is significantly driving the demand for osseointegration implants due to their crucial role in restoring joint health and function.

In addition, data from the Organization for Economic Co-operation and Development (OECD) shows that in 2021, Switzerland recorded 273 knee replacements per 100,000 people, while Finland reported an even higher rate of 260 knee replacements per 100,000 people. The growing number of knee replacement surgeries is expected to further propel the global osseointegration implants market.

Furthermore, the increase in road traffic accidents is another key factor contributing to market growth. As per WHO (2023) data, around 20 to 50 million people suffer non-fatal injuries annually from road accidents, many resulting in long-term disabilities. Injuries such as traumatic amputations, severe fractures, and joint damage often require advanced orthopedic interventions like osseointegration implants, thereby boosting market demand.

Osseointegration Implants Market Drivers:

*
Increasing prevalence of orthopedic conditions

*
Growing number of dental disorders

*
Increasing surge in product approval activities

Get a sneak peek at the Osseointegration Implants market dynamics @ https://www.delveinsight.com/sample-request/osseointegration-implants-market [https://www.delveinsight.com/sample-request/osseointegration-implants-market?utm_source=abnewswire&utm_medium=market&utm_campaign=kpr]

Coverage: Global

Study Period: 2022 to 2032

Key Osseointegration Implants Companies: Medtronic, Stryker, Neoss, Onkos Surgical, CartiHeal Ltd., RevBio, Inc., ZimVie Inc., Zimmer Biomet, OSSTEM IMPLANT CO., LTD., CONMED Corporation, Smith & Nephew, BioHorizons, Camlog, Straumann AG Group, Align Technology, Inc., BEGO GmbH and Co. KG, MEGA'GEN IMPLANT CO.,LTD., Henry Schein, Inc., MIS Implants Technologies, Nobel Biocare, and others.

Which MedTech key players in the Osseointegration Implants market are set to emerge as the trendsetter, explore @ Osseointegration Implants Companies [https://www.delveinsight.com/report-store/osseointegration-implants-market?utm_source=abnewswire&utm_medium=market&utm_campaign=kpr]

Table of Contents

1. Osseointegration Implants Market Report Introduction

2. Osseointegration Implants Market Executive Summary

3. Competitive Landscape

4. Regulatory Analysis

5. Osseointegration Implants Market Key Factors Analysis

6. Osseointegration Implants Market Porter's Five Forces Analysis

7. Osseointegration Implants Market Layout

8. Osseointegration Implants Market Company and Product Profiles

9. KOL Views

10. Project Approach

11. About DelveInsight

12. Disclaimer & Contact Us

About DelveInsight

DelveInsight is a premier healthcare business consultant and market research firm, specializing in life sciences. We empower pharmaceutical companies with comprehensive end-to-end solutions designed to enhance performance and drive growth.

Our expert healthcare consulting services offer in-depth market analysis, helping businesses accelerate growth and navigate challenges with actionable, results-driven strategies.

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Kritika Rehani
Email:Send Email [https://www.abnewswire.com/email_contact_us.php?pr=osseointegration-implants-market-set-for-steady-expansion-by-2032-driven-by-innovation-and-growing-surgical-volumes-delveinsight]
Phone: +14699457679
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: Nevada
Country: United States
Website: https://www.delveinsight.com/

Legal Disclaimer: Information contained on this page is provided by an independent third-party content provider. ABNewswire makes no warranties or responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you are affiliated with this article or have any complaints or copyright issues related to this article and would like it to be removed, please contact retract@swscontact.com



This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Osseointegration Implants Market Set for Steady Expansion by 2032, Driven by Innovation and Growing Surgical Volumes | DelveInsight here

News-ID: 3991404 • Views:

More Releases from ABNewswire

Hypercholesterolemia Pipeline 2025: Innovative Clinical Advancements by 25+ Global Leaders - DelveInsight | Featuring companies such as Jiangsu HengRui Medicine Co., Ltd., Merck Sharp & Dohme LLC, Arr
Hypercholesterolemia Pipeline 2025: Innovative Clinical Advancements by 25+ Glob …
DelveInsight's, "Hypercholesterolemia- Pipeline Insight, 2025" report provides comprehensive insights about 25+ companies and 30+ pipeline drugs in Hypercholesterolemia pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. With hypercholesterolemia reaching global epidemic proportions and contributing to comorbid conditions such as
Anaplastic Large Cell Lymphoma Pipeline 2025: Innovative Clinical Developments by 4+ Global Leaders - DelveInsight | Featuring companies such as Nuvalent, Tessa Therapeutics, PersonGen Biotherapeutics
Anaplastic Large Cell Lymphoma Pipeline 2025: Innovative Clinical Developments b …
DelveInsight's, "Anaplastic Large Cell Lymphoma - Pipeline Insight, 2025," report provides comprehensive insights about 4+ companies and 4+ pipeline drugs in Anaplastic Large Cell Lymphoma pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. With anaplastic large cell lymphoma (ALCL)
Metastatic Prostate Cancer Market: Epidemiology, Therapies, and Key Players - DelveInsight | Featuring companies such as AstraZeneca, Arvinas, Madison Vaccines, Phosplatin Therapeutics, Hinova Pharmac
Metastatic Prostate Cancer Market: Epidemiology, Therapies, and Key Players - De …
Metastatic Prostate Cancer companies are Bristol Myers Squibb, Merck, MacroGenics, Daiichi Sankyo, Seagen/Merck, Taiho Pharmaceutical, Modra Pharmaceuticals, Xencor, Point Biopharma, Lantheus Holdings, Zenith Epigenetics, Essa Pharma, Telix Pharmaceuticals, Kintor Pharmaceutical, AB Science, Eli Lilly and Company, Exelixis, and others. Emerging therapies for metastatic prostate cancer, including NUBEQA (darolutamide), ERLEADA (apalutamide), MGC018 (vobramitamab duocarmazine), Bavdegalutamide (ARV-110), and others, are expected to drive growth in the metastatic prostate cancer market in the coming
Cabinets 4 Less Mesa Brings Affordable Cabinet Solutions to East Valley Homeowners
Cabinets 4 Less Mesa Brings Affordable Cabinet Solutions to East Valley Homeowne …
Cabinets 4 Less Mesa, a cabinet store located at 535 W Iron Ave, Suite 129 in Mesa, AZ, offers affordable ready-to-assemble and semi-custom cabinetry for kitchens, bathrooms, and more. Serving homeowners and contractors across the East Valley, the store combines value, quality, and personalized service, making it a go-to resource for remodeling projects. Learn more at cabinets4lessaz.com MESA, AZ - September 30, 2025 - Cabinets 4 Less Mesa [https://cabinets4lessaz.com], a full-service

All 5 Releases


More Releases for Implants

Aesthetic Implants Market Aesthetic Implants Market
Aesthetic implants are used to improve and rectify the visual deformities of an individual caused due to congenital disorders, trauma or accidents. In addition to cosmetic purpose, these implants are also user for reconstructive processes to enhance aesthetics of patients. Breast augmentation and dental implantations are the most common examples of procedures that incorporate the use of these implants. Click to GET PDF Copy at https://www.theinsightpartners.com/sample/TIPRE00008190/?utm_source=openpr&utm_medium=10641 The List of Companies- •
Dental Implants Market Analysis By Type(Endosteal Implants, Subperiosteal Implan …
In 2021, the market for Dental Implants worldwide was worth $ 3.60 billion US dollars. AMR Group projects that the market will reach US$ 8.50 billion by 2031, growing at a CAGR of 6.5 percent between 2022 and 2031. Industry Overview Dental Implants are the artificially made teeth roots that are operated and placed at the missing tooth's. Normally, the implants are operated and placed below the gums in the jawbone with
Spinal Implants Market by Product (Fusion Spinal Implants and Non-Fusion Spinal …
The spinal implants are inserted in patients with serious back and neck pain. These implants are used to correct deformities, facilitate fusion and alleviate & strengthen the spine. The major conditions that require spinal surgery includes chronic degenerative disc disease, slippage of the spine (Spondylolisthesis), traumatic fracture and other forms of spinal instability including scoliosis. Download Sample PDF at https://www.theinsightpartners.com/sample/TIPHE100000993/?utm_source=OpenPR&utm_medium=10379 Key Players Analysis: The report also includes the profiles of key
Micro-Invasive Glaucoma Implants Micro-Invasive Glaucoma Implants
Global Micro-Invasive Glaucoma Implants Market Definition: Micro-invasive glaucoma implants is performed for the treatment of the open- angle glaucoma and is done through an ab- interno approach. It is very safe and provides faster recovery as compared to the traditional methods. They usually lower the intraocular by increasing the flow or reducing the production of the aqueous humor. Increasing cases of the glaucoma worldwide is the major factor fueling the
Dental Implants Market Outlook 2019: DENTSPLY Implants, Straumann AG, Bicon Dent …
Dental implants are implants in the jaw, placed below the gum line, providing a base for planting artificial teeth or bridge. Dental implants market has witnessed drastic rise in the last few years. A number of socioeconomic and technological factors have contributed to overall growth of the industry. This is primarily attributed to aging baby boomers population with high spending power. Lately, the industry is witnessing change in market dynamics
Dental Implants Market Growth 2016-2024 | Key Players DENTSPLY Implants, Strauma …
The Dental Implants Market is expected to have a highly positive outlook for the next five years 2016-2024 according to a recently released Dental Implants Market research report. The report has been added in his large database by Coherent Market Insights. This report is a guide which covers key strategic developments of the market including acquisitions & mergers, new technology launch, agreements, partnerships, collaborations & joint ventures, research & development,